Image

Treating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation

Treating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation

Non Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to establish a new treatment (repetitive transcranial stimulation (rTMS)) for Veterans with stimulant use disorder (SUD). Despite the large public health burden imposed by SUD, there is currently no FDA-approved or widely recognized effective somatic treatment. rTMS may be a promising treatment option for SUD. In this study, we will demonstrate the feasibility of applying rTMS to Veterans with SUD, examine the efficacy of rTMS in the treatment of SUD, and explore biomarkers that may guide patient selection for rTMS treatment and predict treatment response.

Eligibility

Inclusion Criteria:

  • SCID confirmed diagnosis of SUD, severe
  • Last use of stimulants >1 and <6 weeks
  • Stable medication regimen (no change in dose or agents between 2 weeks prior to the start of and throughout the treatment phase of the study)
  • Stable social environment and housing to enable regular attendance at clinic visits.
  • Ability to undergo cognitive testing, fMRI scans, and rTMS (no contraindications)
  • IQ > 80
  • Stable medical health
  • Veteran at Palo Alto VA's Addiction Treatment Services

Exclusion Criteria:

  • Pregnant or lactating female
  • History of prior adverse reaction to TMS
  • On medications thought to significantly lower seizure threshold, e.g.:
    • clozapine
    • chlorpromazine
    • clomipramine
    • bupropion > 400 mg/day
  • Use of direct dopaminergic antagonists or agonists
  • History of seizures or conditions known to substantially increase risk for seizures
  • Implants or medical devices incompatible with TMS
  • Acute or unstable chronic medical illness that would affect participation or compliance with study procedures, e.g. unstable angina
  • Unstable psychiatric symptoms that precludes consistent participation in the study, e.g.:
    • active current suicidal intent or plan
    • severe psychosis
  • Inability to undergo fMRI scan, e.g. claustrophobia, presence of ferromagnetic objects

    in subject's body

  • Other substance use disorder not in sustained remission
  • Chronic or recurring Axis I psychiatric condition preceding SUD other than PTSD

Study details
    Stimulant Use Disorder
    Substance-related Disorders

NCT04228276

VA Office of Research and Development

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.